RhumbLine Advisers’s Intuitive Surgical ISRG Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $260M | Sell |
652,775
-1,578
| -0.2% | -$689K | 0.2% | 73 |
|
|
2026
Q1 | $302M | Buy |
654,353
+1,886
| +0.3% | +$954K | 0.26% | 58 |
|
|
2025
Q4 | $370M | Sell |
652,467
-20,236
| -3% | -$10.8M | 0.3% | 46 |
|
|
2025
Q3 | $301M | Sell |
672,703
-3,628
| -0.5% | -$1.74M | 0.24% | 63 |
|
|
2025
Q2 | $368M | Sell |
676,331
-10,440
| -2% | -$5.46M | 0.31% | 45 |
|
|
2025
Q1 | $340M | Buy |
686,771
+2,044
| +0.3% | +$1.13M | 0.32% | 44 |
|
|
2024
Q4 | $357M | Sell |
684,727
-8,341
| -1% | -$4.34M | 0.32% | 42 |
|
|
2024
Q3 | $340M | Sell |
693,068
-3,433
| -0.5% | -$1.6M | 0.31% | 46 |
|
|
2024
Q2 | $310M | Buy |
696,501
+16,170
| +2% | +$6.44M | 0.29% | 47 |
|
|
2024
Q1 | $272M | Buy |
680,331
+14,489
| +2% | +$5.47M | 0.26% | 59 |
|
|
2023
Q4 | $225M | Sell |
665,842
-11,611
| -2% | -$3.46M | 0.24% | 75 |
|
|
2023
Q3 | $198M | Buy |
677,453
+3,963
| +0.6% | +$1.24M | 0.23% | 77 |
|
|
2023
Q2 | $230M | Sell |
673,490
-7,298
| -1% | -$2.21M | 0.26% | 65 |
|
|
2023
Q1 | $174M | Buy |
680,788
+20,013
| +3% | +$4.93M | 0.21% | 86 |
|
|
2022
Q4 | $175M | Buy |
660,775
+24,729
| +4% | +$6.03M | 0.24% | 82 |
|
|
2022
Q3 | $119M | Buy |
636,046
+13,596
| +2% | +$2.92M | 0.18% | 105 |
|
|
2022
Q2 | $125M | Buy |
622,450
+25,148
| +4% | +$5.9M | 0.18% | 98 |
|
|
2022
Q1 | $180M | Sell |
597,302
-1,910
| -0.3% | -$558K | 0.23% | 78 |
|
|
2021
Q4 | $215M | Buy |
599,212
+4,336
| +0.7% | +$1.49M | 0.26% | 67 |
|
|
2021
Q3 | $197M | Sell |
594,876
-6,657
| -1% | -$2.24M | 0.27% | 70 |
|
|
2021
Q2 | $184M | Sell |
601,533
-21,435
| -3% | -$6.01M | 0.24% | 74 |
|
|
2021
Q1 | $153M | Sell |
622,968
-39,906
| -6% | -$10M | 0.21% | 87 |
|
|
2020
Q4 | $181M | Sell |
662,874
-13,176
| -2% | -$3.27M | 0.25% | 73 |
|
|
2020
Q3 | $160M | Sell |
676,050
-11,445
| -2% | -$2.57M | 0.25% | 74 |
|
|
2020
Q2 | $131M | Buy |
687,495
+36,003
| +6% | +$6.45M | 0.22% | 82 |
|
|
2020
Q1 | $108M | Buy |
651,492
+16,071
| +3% | +$2.94M | 0.23% | 89 |
|
|
2019
Q4 | $125M | Buy |
635,421
+138
| +0% | +$25.8K | 0.21% | 91 |
|
|
2019
Q3 | $114M | Buy |
635,283
+10,974
| +2% | +$1.9M | 0.21% | 92 |
|
|
2019
Q2 | $109M | Sell |
624,309
-21,834
| -3% | -$3.74M | 0.2% | 91 |
|
|
2019
Q1 | $123M | Buy |
646,143
+28,212
| +5% | +$5.01M | 0.24% | 79 |
|
|
2018
Q4 | $98.6M | Buy |
617,931
+6,459
| +1% | +$1.09M | 0.21% | 87 |
|
|
2018
Q3 | $117M | Sell |
611,472
-11,628
| -2% | -$2.06M | 0.23% | 83 |
|
|
2018
Q2 | $99.4M | Buy |
623,100
+10,314
| +2% | +$1.57M | 0.2% | 95 |
|
|
2018
Q1 | $84.3M | Sell |
612,786
-8,436
| -1% | -$1.18M | 0.18% | 115 |
|
|
2017
Q4 | $75.6M | Buy |
621,222
+10,752
| +2% | +$1.35M | 0.15% | 138 |
|
|
2017
Q3 | $70.9M | Buy |
610,470
+22,509
| +4% | +$2.45M | 0.15% | 129 |
|
|
2017
Q2 | $61.1M | Sell |
587,961
-97,470
| -14% | -$9.37M | 0.14% | 150 |
|
|
2017
Q1 | $58.4M | Buy |
685,431
+21,321
| +3% | +$1.68M | 0.14% | 150 |
|
|
2016
Q4 | $46.8M | Buy |
664,110
+39,510
| +6% | +$2.9M | 0.12% | 181 |
|
|
2016
Q3 | $50.3M | Buy |
624,600
+25,605
| +4% | +$1.96M | 0.14% | 150 |
|
|
2016
Q2 | $44M | Buy |
598,995
+53,964
| +10% | +$3.8M | 0.13% | 153 |
|
|
2016
Q1 | $36.4M | Buy |
545,031
+15,804
| +3% | +$979K | 0.11% | 180 |
|
|
2015
Q4 | $32.1M | Buy |
529,227
+4,077
| +0.8% | +$229K | 0.1% | 194 |
|
|
2015
Q3 | $26.8M | Buy |
525,150
+7,920
| +2% | +$449K | 0.09% | 222 |
|
|
2015
Q2 | $27.8M | Buy |
517,230
+56,970
| +12% | +$3.19M | 0.09% | 228 |
|
|
2015
Q1 | $25.8M | Sell |
460,260
-1,116
| -0.2% | -$63.2K | 0.07% | 243 |
|
|
2014
Q4 | $27.1M | Sell |
461,376
-13,599
| -3% | -$757K | 0.08% | 235 |
|
|
2014
Q3 | $24.4M | Sell |
474,975
-27,648
| -6% | -$1.37M | 0.07% | 241 |
|
|
2014
Q2 | $23M | Sell |
502,623
-95,616
| -16% | -$4.22M | 0.07% | 269 |
|
|
2014
Q1 | $29.1M | Sell |
598,239
-14,526
| -2% | -$684K | 0.09% | 215 |
|
|
2013
Q4 | $26.1M | Sell |
612,765
-66,996
| -10% | -$2.82M | 0.08% | 237 |
|
|
2013
Q3 | $28.4M | Sell |
679,761
-13,086
| -2% | -$578K | 0.09% | 212 |
|
|
2013
Q2 | $39M | Buy |
+692,847
| New | +$38.2M | 0.13% | 166 |
|
Other funds holding ISRG
RhumbLine Advisers's ISRG Position: Q2 2026 in Review
RhumbLine Advisers reduced its Intuitive Surgical (ISRG) stake by 0.24% in Q2 2026, selling an estimated $689K and leaving 652,775 shares worth $260M. The position accounts for 0.2% of the portfolio, ranked #73.
RhumbLine Advisers first reported a position in ISRG in Q2 2013 and has held it in 53 quarters since. The position peaked at $370M in Q4 2025. 2,231 funds tracked by Wall St. Rank hold ISRG as of Q2 2026.
- RhumbLine Advisers held 652,775 shares of Intuitive Surgical worth $260M as of Q2 2026.
- RhumbLine Advisers sold 1,578 Intuitive Surgical shares in Q2 2026, an estimated $689K.
- Intuitive Surgical made up 0.2% of RhumbLine Advisers's portfolio in Q2 2026, its #73 holding.
- RhumbLine Advisers first reported a position in Intuitive Surgical in Q2 2013 and has held it in 53 quarters since.
- RhumbLine Advisers's Intuitive Surgical position peaked at $370M in Q4 2025.
- 2,231 funds tracked by Wall St. Rank held Intuitive Surgical as of Q2 2026.
Based on RhumbLine Advisers's 13F filing for Q2 2026, filed 12 Aug 2026.